Legal Experts Weigh in on BPCIA Severability
October 22, 2020
Tony Hagen
The Center for Biosimilars
Axinn partner Chad Landmon was quoted in The Center for Biosimilars article, "Legal Experts Weigh in on BPCIA Severability."
Click here to access the article.